Supplements, peptides, nootropics, and bioactive compounds for health optimization
145 articles
A new review maps the molecular mechanisms by which stress boosts astaxanthin yield in yeast, pointing toward scalable natural production.
Expert reviews rank fisetin and quercetin as top senolytics, with spermidine and resveratrol as supporting players in longevity supplement stacks.
A market analysis of 62 hangover products across UK, Australia, and Japan reveals striking ingredient differences and a complete absence of clinical trial evidence.
A Cochrane review of 107 RCTs finds vitamin D may slightly cut ARI-related doctor visits in under-5s, but evidence remains low-certainty.
New research argues stress-induced testosterone drops are a central brain adaptation, not testicular failure — with major clinical implications.
A 135-patient pediatric study finds obesity and short stature dominate BBS, while hypogonadism and hypothyroidism remain rare in childhood.
A major review finds clinical proof for NAD+ decline with age is sparse, and human trials of NR and NMN show limited efficacy.
A product review breaks down the evidence tiers for four popular longevity supplements and rates the best commercial stacks.
A systematic review of 9 studies finds FSH improves sperm count and motility in normogonadotropic men, but pregnancy benefits remain unproven.
A leading aging researcher audits NMN, urolithin A, spermidine, and more — revealing what actually works and what falls short.
A Stanford drug development expert breaks down why most peptide compounds circulating online lack the safety and efficacy data required for human use.
A novel two-stage fermentation process produces record levels of PQQ and single cell protein using agricultural waste, cutting production costs.
